comscoreOvarian Suppression Can Help Protect Ovarian Function and May Preserve Fertility in Younger Women Being Treated with Chemotherapy

Ovarian Suppression Can Help Protect Ovarian Function and May Preserve Fertility in Younger Women Being Treated with Chemotherapy

Matteo Lambertini, MD, talks about ovarian suppression to preserve fertility during chemotherapy
Jan 4, 2018
00:00
Download
00:00

Preserving fertility after chemotherapy is an important issue for many, many younger women diagnosed with early-stage breast cancer. Dr. Matteo Lambertini presented research at the 2017 San Antonio Breast Cancer Symposium showing that ovarian suppression with a gonadotropin-releasing hormone analogue such as Lupron, Trelstar, or Zoladex, can safely protect ovarian function and may help preserve fertility in younger women being treated with chemotherapy for early-stage disease.

Listen to the podcast to hear Dr. Lambertini explain:

  • why earlier studies on this topic had mixed results

  • the results of the study

  • the side effects of gonadotropin-releasing hormone analogues

  • the strategies he recommends to his younger patients diagnosed with early-stage breast cancer who want to have a child after chemotherapy

About the guest
 
matteo-lambertini-headshot
Matteo Lambertini, MD, PhD

Dr. Matteo Lambertini is adjunct professor of medical oncology at the University of Genova - IRCCS Policlinico San Martino Hospital.

— Last updated on June 29, 2022, 2:45 PM

 
Lilly Oncology

This content made possible by Lilly Oncology.

 
 
Support Breastcancer.org to produce more content like this

Your donation goes directly to what you read, hear, and see on Breastcancer.org.

Donate